Results 311 to 320 of about 5,711,473 (427)
Objective We aimed to characterize patients with hand osteoarthritis (OA) with deteriorating or improving hand pain and to investigate patients achieving good clinical outcome after four years. Methods We used four‐year annual Australian/Canadian Hand Osteoarthritis Index (AUSCAN) pain subscale (range 0–20) measurements from the Hand OSTeoArthritis in ...
Coen van der Meulen+5 more
wiley +1 more source
Importance to understand medical device regulations for accelerating clinical translation. [PDF]
Lu Q+5 more
europepmc +1 more source
From simple customer to warm user; Or, who cares about the maintenance of community innovations?
Stefan Verhaegh
openalex +2 more sources
Objective Despite knowledge that health outcomes vary according to patient characteristics, identity, and geography, including underrepresented populations in arthritis research remains a challenge. We conducted interviews to explore how researchers in arthritis have used equity, diversity, and inclusion (EDI) principles to inform their research ...
Megan M. Thomas+8 more
wiley +1 more source
Analysis of technology innovation efficiency and its impact factors based on DEA-fsQCA method: Evidence from listed seed companies in China. [PDF]
Mo M, Zeng L.
europepmc +1 more source
Objective The study objective was to estimate the budget impact of funding a standardized education and exercise therapy program, Good Life with osteoArthritis in Denmark (GLA:D) for people with hip and knee osteoarthritis (OA) waiting for total joint replacement (TJR) consultation in a universal publicly insured health care system in Canada.
Darren R. Mazzei+4 more
wiley +1 more source
Retraction: The influence of machine learning-based knowledge management model on enterprise organizational capability innovation and industrial development. [PDF]
PLOS One Editors.
europepmc +1 more source
Relationship Between Gout Flare States and Patient‐Reported Outcomes After Allopurinol Initiation
Objective Gout flares are the most important clinical feature of the disease. A hypothetical maximum flare occurrence in the preceding six months has been suggested to be no flares for a patient‐acceptable symptom state (PASS) and only one flare for low disease activity (LDA).
Lisa K. Stamp+6 more
wiley +1 more source
Pandemic and epidemic intelligence innovation forum: bridging gaps in epidemic intelligence through global collaboration. [PDF]
Tornimbene B, Leiva Rioja ZB, Morgan O.
europepmc +1 more source